Samsung Biologics has newly appeared among the top searched stocks.


As of 2:31 PM on the 10th, Samsung Biologics is trading at 689,000 KRW, up 0.29% from the previous day. This is a 15.15% decrease compared to February 5. Samsung Biologics is known as the holding company for Samsung Group's bio business.

Today, foreigners have net sold 3,150 shares of Samsung Biologics, while institutions have net bought 2,000 shares, according to provisional data. Over the past five days, individual investors have net bought 106,371 shares, whereas foreigners and institutions have net sold 76,779 shares and 32,039 shares respectively.





[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)

※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing